Administration of high titer convalescent anti-SARS-CoV-2 plasma: From donor selection to monitoring recipient outcomes

Early in the SARS-CoV-2 pandemic, convalescent plasma (CP) therapy was proposed as a treatment for severely ill patients. We conducted a CP treatment protocol under the Mayo Clinic Extended Access Program at University Hospital Brooklyn (UHB). Potential donors were screened with a lateral flow assay...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Immunol
Main Authors: Mendoza, Rachelle P., Fyke, William, Daniel, David, Gabutan, Elmer, Das, Ballabh, Bajaj, Harsha, Easy, Maxine, Vasileva, Ana, Colbourn, Robert, Alawad, Mouyed, Dehghani, Amir, Lin, Bo, Emechebe, Dokpe, Patel, Purvi, Jabbar, Absia, Nikolov, Dimitar B., Giovaniello, Dominick, Kang, Steven, Tatem, Luis, Bromberg, Kenneth, Augenbraun, Michael, Premsrirut, Prem, Libien, Jenny, Norin, Allen J.
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics. 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7885628/
https://ncbi.nlm.nih.gov/pubmed/33640208
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.humimm.2021.02.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados